Skip to main content
颖泰生物 logo

颖泰生物 — Investor Relations & Filings

Listed IPO May 2024
Ticker · 920819 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 419 across all filing types
Latest filing 2026-01-08 Audit Report / Informat…
Country CN China
Listing Beijing Stock Exchange 920819

About 颖泰生物

https://www.nutrichem.cn/

Nutrichem Company Limited focuses on the research, development, production, and distribution of agrochemical active ingredients and formulations. The product portfolio includes a diverse array of herbicides, fungicides, and insecticides tailored for global agricultural applications. The company provides comprehensive contract development and manufacturing organization (CDMO) services, supporting international partners through the entire product lifecycle from synthesis to commercial-scale production. With a strong emphasis on research and development, Nutrichem utilizes advanced chemical synthesis technologies and process optimization to ensure high-quality output and operational efficiency. Its integrated supply chain and large-scale manufacturing infrastructure enable the delivery of customized crop protection solutions to meet the evolving needs of the global agricultural sector.

Recent filings

Filing Released Lang Actions
四川华信（集团）会计师事务所（特殊普通合伙）关于北京颖泰嘉和生物科技股份有限公司前期会计差错更正专项说明的鉴证报告
Audit Report / Information Classification · 90% confidence The document is a standalone attestation (鉴证报告) by an independent CPA firm on the company’s prior‐period accounting error corrections, including the auditor’s responsibilities, management’s responsibilities, and detailed adjustments. It is not an Annual Report or interim report, nor merely an announcement or officer certification. It matches the definition of an Audit Report / Information. 9M 2025
2026-01-08 Chinese
2024年年度报告摘要（更正后）
Annual Report Classification · 95% confidence The document is titled as an "年度报告摘要" which translates to "Annual Report Summary" and contains detailed financial data for the year 2024, including assets, liabilities, net profit, shareholder structure, and business overview. It references an audit report with an unqualified opinion by an accounting firm, which is typical for annual reports. The document length is 8494 characters, which is substantial and contains actual financial data and management discussion. It is not merely an announcement or a certification. Therefore, this document is the Annual Report itself, not just a publication announcement or summary notice. FY 2024
2026-01-08 Chinese
2024年年度报告（更正后）
Annual Report Classification · 100% confidence The document is a comprehensive report covering the company's annual activities, financial data, management discussion and analysis, risk factors, governance, and detailed financial statements for the fiscal year 2024. It includes audited financial figures, management certifications, and extensive narrative on business operations, industry conditions, and financial performance. The presence of an auditor's unqualified opinion and detailed financial tables confirms this is the full official yearly report. The document length (15,000 characters) and content depth exclude it from being a mere announcement or summary. Therefore, this document fits the definition of an Annual Report (10-K). FY 2024
2026-01-08 Chinese
2025年三季度报告（更正公告）
Regulatory Filings Classification · 95% confidence The document is titled as a '2025 Third Quarter Report Correction Announcement' from Beijing Yingtai Jiahe Biotechnology Co., Ltd. It references the original 2025 Q3 report and details corrections to financial data and accounting errors. The document is relatively short (924 characters) and primarily serves to announce corrections to a previously published quarterly report rather than presenting the full financial statements or substantive financial data itself. It also includes information about board approval of the correction but does not contain the full interim report data. Therefore, this document is an announcement related to a report correction, not the full interim/quarterly report itself. According to the rules, such correction announcements are best classified as Regulatory Filings (RNS) because they do not contain the full financial report but provide regulatory disclosure about corrections.
2026-01-08 Chinese
2025年第三次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 2025 third extraordinary shareholders' meeting of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It includes details about the meeting's convening, attendance, voting results on various proposals, and legal opinions confirming the validity of the meeting and its resolutions. The content focuses on the official voting outcomes and procedural compliance rather than presenting a report or financial data. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and it is not a report itself but an announcement of meeting resolutions and voting results.
2025-12-25 Chinese
北京市康达律师事务所关于北京颖泰嘉和生物科技股份有限公司2025年第三次临时股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 80% confidence The document is a legal opinion (“法律意见书”) issued by a law firm regarding the company’s 2025 third extraordinary shareholders’ meeting, covering the convening procedures, attendees’ qualifications and, importantly, the detailed voting results on each proposal. Although rendered by a law firm, it serves as the official record of vote outcomes at an EGM. This aligns with the ‘Declaration of Voting Results & Voting Rights Announcements’ category (DVA).
2025-12-25 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.